Bleich, H.L., and Schwartz, W.B.: Tris-Buffer (THAM): An Appraisal of Its Physiologic Effects and Clinical Usefulness , New Eng J Med 274:782-786 (
(April 7)
) 1966;.
Kaplan, S.A.: Tris (Hydroxymethyl) Aminomethane (THAM)—A New Buffer for Therapeutic Use , Amer J Dis Child 103:1-3 (
(Jan)
) 1962;.
Nahas, G.G.: Clinical Pharmacology of THAM [tris (hydroxymethyl) aminomethane] , Clin Pharmacol Ther 4:785-803 (
(Nov)
-Dec) 1963;.
Moore, D., and Bernhard, W.F.: Method for Control of Severe Alterations in Acid-Base Equilibrium , Circulation 27: 665-669 (
(April)
) 1963;.
Selmonosky, C.A.; Goetz, R.H.; and State, D.: The Role of Acidosis in the Irreversibility of Experimental Hemorrhagic Shock , J Surg Res 3:491-496 (
(Dec)
) 1963;.
Cosby, R.S., et al: Respiratory Effects of Tris (THAM) in Acidosis and Alkalosis , Clin Pharmacol Ther 5:185-192 (
(March)
-April) 1964;.
Nahas, G.G.: Use of Organic Carbon Dioxide Buffer in vivo , Science 129:782 (
(March 20)
) 1959;.
Kaplan, S.; Fox, R.P.; and Clark, L.C., Jr.: Amine Buffers in the Management of Acidosis: Study of Respiratory and Mixed Acidosis , Amer J Dis Child 103:4-9 (
(Jan)
) 1962;.
Brinkman, G.L.; Brunswick, W.L.; and Whitehouse, F.W.: Use of 2-amino-2-hydroxymethyl-1, 3-propanediol in Correction of Metabolic and Respiratory Acidosis , Ann NY Acad Sci 92: 735-742 (
(June)
) 1961;.
Hinshaw, J.R.; Cramer, L.M.; and Miller, H.C.: Tris-Buffer in Treatment of Severely Burned Patients , Surgery 56:505-508 (
(Sept)
) 1964;.
Israels, S., in discussion, Strauss, J., et al: Effects of 2-amino-2-hydroxymethyl-1, 3-propanediol on Renal Function in Reference to Salicylate and Glucose , Ann NY Acad Sci 92:579-595 (
(June)
) 1961;.
Peirce, E.C., II: Correction of Acidosis With Tris (hydroxymethyl) aminomethane , Arch Surg 80:693-697 (
(April)
) 1960;.
Stahlman, M.: Treatment of Cardiovascular Disorders of Newborn , Pediat Clin N Amer 11:363-400 (
(May)
) 1964;.
Roberts, M., and Linn, S.: Acute and Subchronic Toxicity of 2-amino-2-hydroxymethyl-1, 3-propanediol , Ann NY Acad Sci 92:724-734 (
(June)
) 1961;.
Brinkman, G.L., et al: Treatment of Respiratory Acidosis With THAM , Amer J Med Sci 239:341-346 (
(March)
) 1960;.
Nahas, G.G.: Pharmacology of Tris (hydroxymethyl) aminomethane (THAM) , Pharmacol Rev 14:447-472 (
(Sept)
) 1962;.
Tarail, R., and Bennett, T.E.: Hypoglycemic Activity of Tris-Buffer in Man and Dog , Proc Soc Exp Biol Med 102:208-209 (
(Oct)
) 1959;.
Parker, R.C.: Methods of Tissue Culture , ed 3, New York: Harper & Row, Publishers, Inc., 1961;.
Martin, G.M.: Use of Tris (hydroxymethyl) aminomethane Buffers in Cultures of Diploid Human Fibroblasts ; Proc Soc Exp Biol Med 116:167-171 (
(May)
) 1964;.
Bras, G., and McLean, E.: Toxic Factors in Veno-occlusive Disease , Ann NY Acad Sci 111:392-398 (
(Dec)
) 1963;.
McLean, E.; Bras, G.; and György, P.: Veno-occlusive Lesions in Livers of Rats Fed Crotalaria fulva, Brit J Exp Path 45:242-247 (
(June)
) 1964;.
McLean, E.; Bras, G.; and McLean, A.E.M.: Venous Occlusions in the Liver Following Dimethylnitrosamine , Brit J Exp Path 46:367-369 (
(Aug)
) 1965;.